Cream with milk peptide for children's mild eczema
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This trial tests if a special cream made with a milk protein peptide can improve mild eczema symptoms like itching and reduce bacteria on the skin in children aged 2 to 12.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 2 and 12 years old.
- Your child has been diagnosed with mild eczema by a doctor.
- Your child's eczema is mild, with a score of less than 25 on a standard measure.
- You are willing to sign a consent form for your child to join the study.
- Your child does not have any other skin conditions or allergies to the cream ingredients.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new cream called JYP0066 for people with mild-to-moderate atopic dermatitis (eczema). It aims to see if the cream safely reduces itching and skin inflammation. It might help if you have tried other creams and still have symptoms.
This trial tests a 2% cholesterol cream to see if it helps children with mild to moderate eczema on their inner elbows. It's designed for Thai children aged 7 to 17 who are not using strong immune-suppressing drugs.
This trial tests whether using CeraVe moisturizer can keep your skin hydrated and prevent flare-ups after your eczema has been cleared with a steroid treatment. It is for adults with mild to moderate eczema that gets better with steroids.
This trial tests whether a special herbal ointment can help treat atopic dermatitis (eczema). It is for adults with mild, moderate, or severe eczema covering less than 10% of their body surface. The ointment is applied directly to the skin, and participants will also use a gentle, fragrance-free moisturizer.
This trial tests a new dermocosmetic cream for children with eczema. It looks at how well the cream works and how gentle it is on the skin, after the child uses a prescribed steroid cream to calm a flare-up.
This study tests a new cream (CMS-D001) for people with moderate to severe eczema. Participants will receive either the study cream or a placebo (a cream with no active ingredient) to see if it helps reduce symptoms like itching and redness.
Hear when a new Atopic Dermatitis (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.